Literature DB >> 17211832

A combined dataset of human cerebrospinal fluid proteins identified by multi-dimensional chromatography and tandem mass spectrometry.

Sheng Pan1, David Zhu, Joseph F Quinn, Elaine R Peskind, Thomas J Montine, Biaoyang Lin, David R Goodlett, Greg Taylor, Jimmy Eng, Jing Zhang.   

Abstract

Human cerebrospinal fluid (CSF) is an important source for studying protein biomarkers of age-related neurodegenerative diseases. Before characterizing biomarkers unique to each disease, it is necessary to categorize CSF proteins systematically and extensively. However, the enormous complexity, great dynamic range of protein concentrations, and tremendous protein heterogeneity due to post-translational modification of CSF create significant challenges to the existing proteomics technologies for an in-depth, nonbiased profiling of the human CSF proteome. To circumvent these difficulties, in the last few years, we have utilized several different separation methodologies and mass spectrometric platforms that greatly enhanced the identification coverage and the depth of protein profiling of CSF to characterize CSF proteome. In total, 2594 proteins were identified in well-characterized pooled human CSF samples using stringent proteomics criteria. This report summarizes our efforts to comprehensively characterize the human CSF proteome to date.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17211832     DOI: 10.1002/pmic.200600756

Source DB:  PubMed          Journal:  Proteomics        ISSN: 1615-9853            Impact factor:   3.984


  39 in total

Review 1.  Biochemical premotor biomarkers for Parkinson's disease.

Authors:  Brit Mollenhauer; Jing Zhang
Journal:  Mov Disord       Date:  2012-04-15       Impact factor: 10.338

Review 2.  Biomarkers for cognitive impairment in Parkinson disease.

Authors:  Min Shi; Bertrand R Huber; Jing Zhang
Journal:  Brain Pathol       Date:  2010-05       Impact factor: 6.508

3.  Quantitative proteomic analysis of oligodendrogliomas with and without 1p/19q deletion.

Authors:  Robert C Rostomily; Donald E Born; Richard P Beyer; Jinghua Jin; Ellsworth C Alvord; Andrei M Mikheev; Russell T Matthews; Catherine Pan; Leila Khorasani; Josh A Sonnen; Thomas J Montine; Min Shi; Jing Zhang
Journal:  J Proteome Res       Date:  2010-05-07       Impact factor: 4.466

4.  In-depth exploration of cerebrospinal fluid by combining peptide ligand library treatment and label-free protein quantification.

Authors:  Emmanuelle Mouton-Barbosa; Florence Roux-Dalvai; David Bouyssié; François Berger; Eric Schmidt; Pier Giorgio Righetti; Luc Guerrier; Egisto Boschetti; Odile Burlet-Schiltz; Bernard Monsarrat; Anne Gonzalez de Peredo
Journal:  Mol Cell Proteomics       Date:  2010-01-21       Impact factor: 5.911

5.  CSF-PR 2.0: An Interactive Literature Guide to Quantitative Cerebrospinal Fluid Mass Spectrometry Data from Neurodegenerative Disorders.

Authors:  Astrid Guldbrandsen; Yehia Farag; Ann Cathrine Kroksveen; Eystein Oveland; Ragnhild R Lereim; Jill A Opsahl; Kjell-Morten Myhr; Frode S Berven; Harald Barsnes
Journal:  Mol Cell Proteomics       Date:  2016-11-27       Impact factor: 5.911

Review 6.  Meningiomas and Proteomics: Focus on New Potential Biomarkers and Molecular Pathways.

Authors:  Rosaria Viola Abbritti; Francesca Polito; Maria Cucinotta; Claudio Lo Giudice; Maria Caffo; Chiara Tomasello; Antonino Germanò; Mohammed Aguennouz
Journal:  Cancer Genomics Proteomics       Date:  2016 09-10       Impact factor: 4.069

Review 7.  Cerebrospinal fluid analysis in Alzheimer's disease: technical issues and future developments.

Authors:  Simone Lista; Henrik Zetterberg; Bruno Dubois; Kaj Blennow; Harald Hampel
Journal:  J Neurol       Date:  2014-05-08       Impact factor: 4.849

8.  Proteomic and metabolomic strategies to investigate HIV-associated neurocognitive disorders.

Authors:  Gurudutt Pendyala; Howard S Fox
Journal:  Genome Med       Date:  2010-03-30       Impact factor: 11.117

9.  Establishing the proteome of normal human cerebrospinal fluid.

Authors:  Steven E Schutzer; Tao Liu; Benjamin H Natelson; Thomas E Angel; Athena A Schepmoes; Samuel O Purvine; Kim K Hixson; Mary S Lipton; David G Camp; Patricia K Coyle; Richard D Smith; Jonas Bergquist
Journal:  PLoS One       Date:  2010-06-11       Impact factor: 3.240

10.  Identification of novel biomarker candidates by proteomic analysis of cerebrospinal fluid from patients with moyamoya disease using SELDI-TOF-MS.

Authors:  Yoshio Araki; Kazuhiro Yoshikawa; Sho Okamoto; Masaki Sumitomo; Mikio Maruwaka; Toshihiko Wakabayashi
Journal:  BMC Neurol       Date:  2010-11-08       Impact factor: 2.474

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.